Juha Kirveskari
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria 12
- Endocrinology top 1%
- Vibrio bacteria research studies 5
- Infectious Diseases top 5%
- Viral gastroenteritis research and epidemiology 9
- Hepatology top 5%
- Hepatitis Viruses Studies and Epidemiology 7
-
- Travel-related health issues 13
-
- Salmonella and Campylobacter epidemiology 8
-
- Cell Adhesion Molecules Research 8
-
- Immune Response and Inflammation 5
- Co-authors
- Anu KanteleTinja LääveriJenni AntikainenSointu MeroSari H. PakkanenKaisa GranforsMartti VaaraPäivi Tissari
- Partner nations
- FinlandSwedenUnited States
In The Last Decade
Juha Kirveskari
53 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 103
- Molecular Medicine 402
- Endocrinology 356
- Applied Microbiology and Biotechnology 111
- Infectious Diseases 531
- Hepatology 139
Countries citing papers authored by Juha Kirveskari
This map shows the geographic impact of Juha Kirveskari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juha Kirveskari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juha Kirveskari more than expected).
Fields of papers citing papers by Juha Kirveskari
This network shows the impact of papers produced by Juha Kirveskari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juha Kirveskari. The network helps show where Juha Kirveskari may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Juha Kirveskari, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 8 | |
| 2 | 2023 | 6 | |
| 3 | 2022 | 24 | |
| 4 | 2020 | 13 | |
| 5 | 2020 | 21 | |
| 6 | 2017 | 23 | |
| 7 | 2017 | 41 | |
| 8 | 2016 | 48 | |
| 9 | 2015 | 13 | |
| 10 | 2014 | 40 | |
| 11 | 2014 | 19 | |
| 12 | 2014 | 36 | |
| 13 | 2014 | 34 | |
| 14 | 2011 | 14 | |
| 15 | 2009 | 37 | |
| 16 | 2004 | 15 | |
| 17 | 2004 | 2 | |
| 18 | 2001 | 22 | |
| 19 | 2000 | 38 | |
| 20 | 1999 | 16 |
About Juha Kirveskari
Juha Kirveskari is a scholar working on Molecular Medicine, Endocrinology and Applied Microbiology and Biotechnology, having authored 53 papers that have together received 1.7k indexed citations. Recurring topics across this work include Travel-related health issues (13 papers), Antibiotic Resistance in Bacteria (12 papers), Viral gastroenteritis research and epidemiology (9 papers), Salmonella and Campylobacter epidemiology (8 papers), Cell Adhesion Molecules Research (8 papers), Hepatitis Viruses Studies and Epidemiology (7 papers), Vibrio bacteria research studies (5 papers) and Immune Response and Inflammation (5 papers). The work is most often cited by research in Molecular Medicine (402 citations), Endocrinology (356 citations) and Applied Microbiology and Biotechnology (111 citations). Juha Kirveskari has collaborated with scholars based in Finland, Sweden and United States. Frequent co-authors include Anu Kantele, Tinja Lääveri, Jenni Antikainen, Sointu Mero, Sari H. Pakkanen, Kaisa Granfors, Martti Vaara, Päivi Tissari, Jukka Ollgren and Risto Renkonen. Their work appears in journals such as Journal of Biological Chemistry, Nature Medicine and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.